March 10, 2016
Sanofi and MSD/Merck in joint vaccines operations in Europe
Sanofi and MSD/Merck in joint vaccines operations in Europe
Pharmaceuticals, Biotechnology and Life Sciences
Category: Regions
March 10, 2016
Premaitha signs distribution agreement with GeNext in Russia
Premaitha signs distribution agreement with GeNext in Russia
March 7, 2016
Pharma crusader takes India’s drug regulators to court
One of India’s best-known whistleblowers, who exposed dangerous practices in the generic drug industry in 2013, is taking the country’s drugs regulators to court, accusing them of failing to enforce rules on drug safety in the $15 billion (11 billion pound) industry.
February 17, 2016
Durvalumab granted BTD by FDA for cancer patients
AstraZeneca and MedImmune, its global biologics research and development arm, on Wednesday announced that the US Food and Drug Administration (FDA) has granted Breakthrough Therapy designation (BTD) for durvalumab (MEDI4736), an investigational human monoclonal antibody directed against programmed death ligand-1 (PD-L1), for the treatment of patients with PD-L1 positive inoperable or metastatic urothelial bladder cancer whose tumour has progressed during or after one standard platinum-based regimen.
February 2, 2016
Premaitha partners with Leeds Teaching Hositals NHS Trust to provide NIPT screening service
Premaitha Health, the developer of IONA test, has partnered with Leeds Teaching Hospitals NHS Trust to provide a private NIPT…
January 21, 2016
Glenmark Pharmaceuticals entering $130M market with two new generic medicines
Glenmark Pharmaceuticals entering $130M market with Actavis’ Potassium Cholire capsules and generics of Warner Chilcott’s Loestrin tablets
January 21, 2016
Indian Natco to sell Bristol-Myer Squibb’s hepatitis C medicine in 112 countries
Indian pharmaceutical company Natco Pharma Limited has signed a nonexclusive, royalty free licensing agreement with the Medicines Patent Pool and…
January 20, 2016
German Biofrontera leaving London Stock Exchange
Biofrontera, the biopharmaceutical company focusing on sun-induced skin cancer, has decided to cancel the admission of its ordinary shares to trading…
January 18, 2016
Eurostars grant awarded to international consortium including Abzena company, Antitope, for development of novel treatment for clotting disorders
Eurostars grant awarded to international consortium including Abzena company, Antitope, for development of novel treatment for clotting disorders
January 15, 2016
French drug trial disaster leaves one brain dead, five injured
One person has been left brain dead and five others have been hospitalised after taking part in a clinical trial in France of an experimental drug made by Portuguese drug company Bial, French Health Minister Marisol Touraine said on Friday.